3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
10
Lung Neoplasms
5
Prostatic Neoplasms
4
Breast Neoplasms
4
Oropharyngeal Neoplasms
3
Neoplasms
3
Endometrial Neoplasms
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumonia
1
Pleuropulmonary blastoma
1
Pathologic Complete Response
1
Paranasal Sinus Neoplasms
1
Pancreatitis, Chronic
1
Obesity
1
Neurocognitive Disorders
1
Neuroblastoma
1
Neoplasm Metastasis
1
Interventions
Rituximab
27
ibrutinib
13
acalabrutinib
13
CT-P10
12
Lenalidomide
11
Cyclophosphamide
11
zanubrutinib
9
Specimen Handling
8
Magnetic Resonance Spectroscopy
8
venetoclax
7
pirtobrutinib
7
obinutuzumab
7
Cytarabine
7
Biopsy
7
glofitamab
6
fludarabine
5
Bendamustine Hydrochloride
5
fludarabine phosphate
4
brexucabtagene autoleucel
4
Vincristine
4
Peripheral Blood Stem Cell Transplantation
4
Doxorubicin
4
Etoposide
3
Cyclosporine
3
pembrolizumab
2
palbociclib
2
merphos
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
Observation
×
90 days
×
Clear all
No trials found.